Evidence map›Paper›PMID 40551263›Full record

ArticleParasites & vectors2025

Significant variations in tolerance to clothianidin and pirimiphos-methyl in Anopheles gambiae and Anopheles funestus populations during a dramatic malaria resurgence despite sustained indoor residual spraying in Uganda.

Ambrose Oruni, Emmanuel Arinaitwe, James Adiga, Geoffrey Otto, Patrick Kyagamba, Joseph Okoth, Daniel Ayo, Jackson Rwatooro Asiimwe, Maato Zedi, John Rek and 12 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Ambrose OruniInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda. orambrose@yahoo.com.
Emmanuel ArinaitweInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
James AdigaInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Geoffrey OttoInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Patrick KyagambaInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Joseph OkothInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Daniel AyoInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Jackson Rwatooro AsiimweInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Maato ZediInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
John RekInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Kyle J WalkerDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Ashlee BraithwaiteDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Jonathan KayondoEntomology Department, Uganda Virus Research Institute, P.O. Box 49, Entebbe, Uganda.
Melissa D ConradUniversity of California San Francisco, San Francisco, USA.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Mark J I PaineDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Hanafy M IsmailDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Paul KrezanoskiUniversity of California San Francisco, San Francisco, USA.
Charles S WondjiCentre for Research in Infectious Diseases, LSTM-Research Unit, P.O BOX 3591, Yaoundé, Cameroon.
Moses R KamyaInfectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, P.O. Box 7475, Kampala, Uganda.
Grant DorseyUniversity of California San Francisco, San Francisco, USA.
Martin J DonnellyDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.

Funding

Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2010 to 2026
$29.3M
Identifying gaps between LLIN use and vector exposure to improve malaria controlK23AI139364 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KREZANOSKI, PAUL JOSEPH · 2019 to 2023
$986k
NIAID NIH HHS K23 AI139364NIAID NIH HHS U19 AI089674NIH Career Mentored Award K23AI139364US National Institutes of Health (NIH) U19AI089674
6 · The paper itself

Abstract

backgroundA dramatic malaria resurgence occurred in areas of Uganda between 2020 and 2022, coinciding with the switch to clothianidin-based formulations for indoor residual spraying. During the resurgence, Anopheles funestus sensu lato (s.l.) numbers increased more than those of Anopheles gambiae s.l., but when an alternative insecticide, pirimiphos-methyl, was reintroduced in 2023, both malaria cases and An. funestus mosquito density fell.

methodsIn this study, we investigated possible causes of the resurgence by assessing (1) whether sufficient quantities of insecticide were sprayed, (2) the residual insecticide bio-efficacy against wild mosquitoes, and (3) the insecticide susceptibility of both key vector populations using standard test tube assays and wall cone assays.

resultsIn 2023, after adjusting for extraction efficiency, 70-80% of the houses had optimal residual concentrations of insecticides (clothianidin > 0.3g/m

conclusionsDespite the possible variations observed in spray operations, the study revealed that An. funestus s.l. exhibited a higher tolerance to clothianidin-based formulations compared to An. gambiae s.l., and this might have driven the malaria resurgence observed in Uganda. However, there are signals of An. gambiae s.l. resistance to pirimiphos-methyl, which will require further investigation and monitoring.

Indexed as

AnophelesGuanidinesInsecticide ResistanceInsecticidesMalariaNeonicotinoidsOrganothiophosphorus CompoundsThiazolesAnimalsFemaleMosquito ControlMosquito VectorsUgandaclothianidinGuanidinesInsecticidesNeonicotinoidsOrganothiophosphorus Compoundspirimiphos methylThiazolesActellic 300CSAnopheles funestusAnopheles gambiaeClothianidinIndoor residual sprayingMalaria resurgencePirimiphos-methylSumishield 50WGTolerance

Identifiers

PMID40551263
PMCPMC12183807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.